Surgery Partners receives ‘buy’ rating: 4 quick facts

Analysts rated Nashville, Tenn.-based Surgery Partners shares a “buy,” according to Sports Perspective.

Advertisement

Here are four quick facts:

1. Analysts have a $20.86 one-year price target on Surgery Partners shares.

2. On Jan. 26, 2017, Surgery Partners shares opened the day trading at $19.15 per share.

3. The company’s market cap is $828.64 million.

4. The P/E ratio is 98.71.

More articles on surgery centers:
Surgery Partners opens ophthalmology-driven ASC — 3 highlights
Carle gets green light to relocate ASC — 4 notes
Christ Hospital’s dispute with St. Elizabeth Healthcare over $24M ASC may wage on for years

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.